FDA Approves Novo Nordisk’s Rybelsus For Cardiovascular Risk Reduction In Type 2 Diabetes Patients Finances October 18, 2025 (RTTNews) – Novo Nordisk introduced that the US Meals and Drug Administration has permitted Rybelsus—the one oral GLP-1 remedy—for decreasing…
Post-Ozempic patients may eat more calories, Deutsche Bank survey finds Markets January 10, 2024 A buyer retailers in a Kroger grocery retailer on July 15, 2022 in Houston, Texas.Brandon Bell | Getty PhotosTraders have…
